Genetic Signatures Limited (ASX: GSS)

Genetic Signatures Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	148	155	75	166	157	307
Market Cap Growth	105.87%	105.87%	-54.74%	5.81%	-48.73%	118.33%
Enterprise Value	113	137	48	129	121	267
Last Close Price	0.65	0.72	0.51	1.13	1.07	2.10
PE Ratio	-	-	-	54.30	89.52	-
PS Ratio	7.80	11.26	3.50	4.69	5.54	22.19
PB Ratio	2.29	2.54	1.75	3.04	3.19	6.68
P/TBV Ratio	2.83	2.83	2.01	3.13	3.21	6.69
P/FCF Ratio	-	-	-	20.56	-	-
P/OCF Ratio	-	-	-	16.96	37.47	-
EV/Sales Ratio	8.18	9.94	2.25	3.64	4.28	19.33
EV/EBITDA Ratio	-	-	-	30.00	47.44	-
EV/EBIT Ratio	-	-	-	42.56	79.51	-
EV/FCF Ratio	-9.30	-	-	15.95	-	-
Debt / Equity Ratio	0.02	0.02	-	0.00	0.01	0.02
Debt / EBITDA Ratio	-	-	-	0.01	0.14	-
Debt / FCF Ratio	-	-	-	0.00	-	-
Asset Turnover	0.24	0.24	0.40	0.62	0.55	0.45
Inventory Turnover	1.02	1.02	1.25	1.22	1.16	1.28
Quick Ratio	8.76	8.76	4.55	8.54	7.68	11.67
Current Ratio	10.04	10.04	5.99	10.66	10.30	13.84
Return on Equity (ROE)	-34.34%	-34.34%	-28.76%	5.88%	3.69%	-7.38%
Return on Assets (ROA)	-19.69%	-19.69%	-16.78%	3.33%	1.84%	-4.60%
Return on Capital (ROIC)	-21.77%	-21.77%	-18.66%	3.62%	1.98%	-4.97%
Earnings Yield	-16.63%	-11.52%	-18.66%	1.84%	1.12%	-0.68%
FCF Yield	-8.20%	-7.81%	-19.10%	4.86%	-0.29%	-3.84%
Buyback Yield / Dilution	-15.25%	-15.25%	1.40%	0.16%	-14.76%	-22.06%
Total Shareholder Return	-15.25%	-15.25%	1.40%	0.16%	-14.76%	-22.06%

Source: S&P Capital IQ. Standard template. Financial Sources.